GREGORY A LIZEE to Tumor Microenvironment
This is a "connection" page, showing publications GREGORY A LIZEE has written about Tumor Microenvironment.
Connection Strength
0.486
-
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013 Mar 01; 19(5):1225-31.
Score: 0.192
-
Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells. 2021 09 10; 10(9).
Score: 0.087
-
Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40. Blood. 2012 Nov 29; 120(23):4533-43.
Score: 0.047
-
Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma. Clin Cancer Res. 2012 Oct 01; 18(19):5329-40.
Score: 0.046
-
Antitumor activity mediated by CpG: the route of administration is critical. J Immunother. 2011 Apr; 34(3):279-88.
Score: 0.042
-
Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment. Cancer Res. 2024 Apr 01; 84(7):965-976.
Score: 0.026
-
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease. Neuro Oncol. 2023 08 03; 25(8):1415-1427.
Score: 0.025
-
IL-1a Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma. J Immunol. 2021 04 15; 206(8):1966-1975.
Score: 0.021